Leo Rasche, MD, University of Arkansas for Medical Sciences, Little Rock, AR, gives a brief overview of novel targets for the treatment of multiple myeloma and talks on the potential of targeting GPRC5D and FCRH5, as well as highlighting the key role of combination approaches in the future. This interview took place at the virtual European Hematology Association (EHA) Congress 2021.